title: Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.
abstract: In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
authors.affiliation: Department of Clinical Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK. mary.porteous@ed.ac.uk
authors.forename: M
authors.initials: M
authors.lastname: Porteous
authors.forename: M
authors.initials: M
authors.lastname: Dunckley
authors.forename: S
authors.initials: S
authors.lastname: Appleton
authors.forename: S
authors.initials: S
authors.lastname: Catt
authors.forename: M
authors.initials: M
authors.lastname: Dunlop
authors.forename: H
authors.initials: H
authors.lastname: Campbell
authors.forename: A
authors.initials: A
authors.lastname: Cull
mesh_terms: D000328:Adult; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000235:genetics*; D005260:Female; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010358:Patient Participation; D017060:Patient Satisfaction; D012307:Risk Factors